Department of Family and

Community Medicine
Vicente Sotto Memorial Medical Center

EVIDENCE BASED MEDICINE

“Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in
the Philippines: a case-control study with an urban Filipino population”:
A Journal Appraisal

Submitted to:
Department of Family and Community Medicine
Vicente Sotto Memorial Medical Center

Submitted by:
Aytona, Sherry Mae P.
Calibugar, Van Lendl T.
Constantino, Jehesus Jireh C.
Gonzales, Christian Jerome A.
Minorca, Alexandra Nicole G.
Polayapoy, Mark Andrew S.
Sangre, Hezel Clair C.
Teves, Annah S
Valencia, Jurrine J.
Yap, Eunice T.

November 2019
CLINICAL CASE SCENARIO
 This is the case of M.A., a 68-year-old female from Mandaue City, Cebu who sought consult at
the OPD for routine medical check-up with laboratory results after obtaining the geriatric package.
Patient is a known hypertensive for 5 years maintained on Losartan 50mg/tab, 1 tab once daily and
Amlodipine 5mg/tab 1 tab once daily, with good compliance. Usual blood pressure at home is 130/80
with highest blood pressure of 150/90. Patient noted no other symptoms or subjective complaints. No
other known co-morbidities.

Significant family history include Type II Diabetes Mellitus on the paternal side and Hypertension
on the maternal side.

Patient is a non-smoker, non-alcoholic beverage drinker with no history of illicit drug use.

Upon assessment, patient had stable vital signs with a blood pressure of 120/80 mmHg, heart
rate of 82 bpm, respiratory rate of 16 cpm, and a temperature of 36.5. Anthropometric measurements
were also taken with a height of 160 cm, weight of 65 kgs, BMI of 25.4 m/kg2 (Obese), BSA of 1.70m2,
and waist circumference of.

RESEARCH QUESTION
 What is the most ideal existing risk assessment tool
in pre-diabetic and diabetic Filipinos?

Population Pre-diabetic and Diabetic Filipinos

Intervention Risk assessment
Comparison ADA Risk Assessment, CANRISK, FINRISK
Outcome Prevention or Early Detection of Diabetes
Method Case-Control Design
SEARCH:
https://www.ncbi.nlm.nih.gov/pubmed/
Keywords: diabetes, risk assessment, Philippines, 2019
CRITICAL APPRAISAL OF PROG NOSTIC STUDIES
I. Are the results of the study valid? (Internal Validity)
1. Was the defined representative sample of patients assembled at a
common (usually early) point in the course of their disease?
2. Was patient follow-up sufficiently long and complete?
3. Were outcome criteria either objective or applied in a ‘blind' fashion?
4. If subgroups with different prognoses are identified, did adjustment for
important prognostic factors take place?

II. What are the results?

1. How likely are the outcomes over time?
2. How precise were the prognostic estimates?
3. Can I apply this valid, improtant evidence about prognosis to my
patient?